About Event
Europe’s Premier Platform Uniting Microbiome R&D & Microbial Therapeutics Leaders
The 9th Microbiome Movement Summit Europe was the industry’s definitive event, uniting a driven community at the cutting edge of microbiome research to showcase data unequivocally proving the therapeutic potential of microbial modalities.
As the crucial yearly touchpoint for fresh and familiar faced to collaborate and network, C-Level executives, R&D leaders, commercial experts and investors converged to bridge the translational gap, unlock mechanisms of action and shape agile pipeline strategies that fast-tracked promising programmes to patients.
Key Features for 2025:
You Discovered Clinical Trial Design Optimisations
You analysed effective clinical trial designs for LBPs and Whole-Ecosystem products, focussing on patient selection, recruitment, control measures and combination strategies with Biomica, MRM Health, Maat pharma, and Seres Therapeutics
You Learnt About Emerging Therapeutic Targets in GI & Beyond
You discovered cutting-edge evidence linking microbiota composition and activity to new therapeutic avenues, across the gut-brain axis, women’s health, respiratory, and cardiometabolic disease, through a dedicated focus day
You Navigated the Current Regulatory & Commercial Environment
You reviewed Microbiotica’s regulatory path to Phase I and explore BioGaia Pharma and Luca Bio’s business models to expedite therapeutic development through probiotic pathways. Insights from Seventure, SOSV, EIT Health, M Ventures, CSB, and Innovate UK Business Connect highlighted strategies for driving engagement with investor stakeholders
You Uncovered Analytical Approaches to Delve into Mechanisms of Action
You explored how spatial biology, AI platforms and multi-omic dataset integration was accelerating target discovery, strain selection and translation to the clinic, as Kanvas Biosciences, PharmaBiome, and Exceliom Biosciences shared methodologies to overcome data integrity challenges
New Presenters In 2025:
Who You Met?
